Cambridge Investment Research Advisors, Inc. Miromatrix Medical Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
SELL
$3.36 - $4.32 $5,040 - $6,480
-1,500 Reduced 2.19%
66,900 $266,000
Q1 2022

May 12, 2022
BUY
$2.03 - $4.73 $64,959 - $151,360
32,000 Added 87.91%
68,400 $270,000
Q4 2021

Feb 03, 2022
BUY
$4.45 - $9.4 $161,980 - $342,160
36,400 New
36,400 $170,000

About Miromatrix Medical Inc.

MIRO Quotes by TradingView
  • Ticker MIRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,899,200
  • Description
  • Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified huma...
More about MIRO
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email